News feature: A few good scientists
Researchers who have no financial entanglements with companies are a rare breed. Given that, asks Meredith Wadman, is the push to police conflicts of interest realistic?
Medical students protest perks from drug companies
Gifts can threaten students' integrity, critics say.
New NIH project could be road to ruin for basic research
The ambitious US National Institutes of Health (NIH) Roadmap for Medical Research arrived in October to glowing press reports and enthusiastic endorsements from top scientists. But some researchers are worried that the plan will give the NIH director authority to set a top-down agenda at the expense of bench scientists.